Cardiol Therapeutics
Investor Insight Cardiol Therapeutics is positioned with a late-stage lead asset, multiple orphan indications, strong clinical proof-of-concept data, and a...
Read moreInvestor Insight Cardiol Therapeutics is positioned with a late-stage lead asset, multiple orphan indications, strong clinical proof-of-concept data, and a...
Read more(TheNewswire) VANCOUVER September 12, 2025 TheNewswire – Providence Gold Mines Inc. (‘Providence’ or the ‘Company’) is pleased to announce a...
Read moreHighlights: The latest drill results build on Bo_RC_14/25 drill hole (previously released as 12.0 metres @ 4.27% WO₃ from 252.0...
Read moreBold Ventures Inc. (TSXV: BOL,OTC:BVLDF) (the ‘Company’ or ‘Bold’) is pleased to announce the results of a prospecting and sampling...
Read moreBrings Company’s Total Claims to 491 in Area Housing the Only Rare Earths Producing Mine in U.S. Move Expands Locksley’s...
Read more